Buscar
Mostrando ítems 1-10 de 1615
Tuberculosis genetic epidemiology: A latin american perspective
(MDPI, 2019)
There are an estimated 10 million new cases of tuberculosis worldwide annually, with 282,000 new or relapsed cases each year reported from the Americas. With improvements in genome sequencing technology, it is now possible ...
Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi
(African Online Scientific Information Systems, 2018)
Background: Rural settings where molecular tuberculosis diagnostics are not currently available need easy-to-use tests that do not require additional processing or equipment. While acid-fast bacilli (AFB) smear is the most ...
Neonatal outcome of children born to women with tuberculosis.
(Elsevier; Instituto Mexicano del Seguro Social, 2001)
A new era for global tuberculosis control
(Elsevier, 2011)
A Lancet Editorial emphasised the need “to move away from the over medicalisation of tuberculosis and recognise its intersection with other sectors” and argued for the role of WHO in this “new era for global tuberculosis ...
Cough dynamics in adults receiving tuberculosis treatment
(Public Library of Science, 2020)
Cough is a characteristic symptom of tuberculosis, is the main cause of transmission, and is used to assess treatment response. We aimed to identify the best measure of cough severity and characterize changes during initial ...
Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia
(Public Library of Science, 2019)
Timely diagnosis of tuberculosis (TB) is limited in Ethiopia. We evaluated the performance of a low technology, thin layer agar, Mycobacterium tuberculosis (M.tb) culture color plate (TB-CX) test with concurrent drug ...
Isoniazid Preventive Therapy in Contacts of Multidrug-resistant Tuberculosis.
(American Thoracic Society, 2020)
RATIONALE: The World Health Organization recommends the use of isoniazid alone or in combination with rifapentine to treat latent tuberculosis infection. The recent rise of drug-resistant tuberculosis has complicated the ...
Impact of intermediate hyperglycaemia as well as diabetes on immune dysfunction in tuberculosis.
(Oxford University Press, 2020)
BACKGROUND: People living with diabetes have an increased risk of developing active tuberculosis and are more likely to have poor tuberculosis-treatment outcomes, which may impact on control of tuberculosis as the prevalence ...